A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)

Clinical trial NCT00320502 · COMPLETED

Trial details

NCT number: NCT00320502
Sponsor: Synvista Therapeutics, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Coronary Syndrome Type 2 Diabetes

Start date: 2006-05-01
Primary completion: 2008-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.